Home » Topics » BioWorld Science

BioWorld Science
RSS

Medulloblastoma murine model dissects its poorly known biology

June 21, 2022

CAMLG gene mutation c.633+4A>G causes a novel neurological phenotype

June 21, 2022

Heterozygous mutations in TMEM163 cause hypomyelinating leukodystrophy

June 20, 2022

Lenire licenses VSN-16R from UCL for fragile X syndrome

June 20, 2022

Studies explore asprosin as a target for treating binge eating

June 20, 2022

RP Scherer Technologies patents TROP-2-targeting antibody-drug conjugates

June 20, 2022

Anti-glypican-3 antibody-drug conjugates developed at Ardeagen

June 20, 2022

2692372 Ontario, Dunad Therapeutics patent tubulin polymerization inhibitors

June 20, 2022

Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors

June 20, 2022

New MRGPRX2 antagonists identified at Bioardis

June 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...